4640 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Abou-Alfa
    Abou-Alfa
  4. Kelsen
    Kelsen
  5. Ilson
    Ilson
  6. Kemeny
    Kemeny
  7. Janjigian
    Janjigian
  8. Reidy
    Reidy
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)
  7. Epidemiology and Biostatistics (828)
  8. GSK Faculty (793)
  9. Department of Pathology and Laboratory Medicine (723)
  10. Biostatistics Service (661)
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of flavopiridol (alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer
    Journal Article

    Carvajal, R. D.; Tse, A.; Shah, M. A.; Lefkowitz, R. A.; Gonen, M.; Gilman-Rosen, L.; Kortmansky, J.; Kelsen, D. P.; Schwartz, G. K.; O'Reilly, E. M.
    Pancreatology (2009)

    Fulltext@MSK | Save
  • P27-Kip1 in stage III colon cancer: Implications for outcome following adjuvant chemotherapy in Cancer and Leukemia Group B protocol 89803
    Journal Article

    Bertagnolli, M. M.; S.Warren, R.; Niedzwiecki, D.; Mueller, E.; Compton, C. C.; Redston, M.; Hall, M.; Hahn, H. P.; Jewell, S. D.; Mayer, R. J.; more...
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • Combined modality treatment of resectable and borderline resectable pancreas cancer: Expert consensus statement
    Journal Article

    Abrams, R. A.; Lowy, A. M.; O'Reilly, E. M.; Wolff, R. A.; Picozzi, V. J.; Pisters, P. W. T.
    Annals of Surgical Oncology (2009)

    Fulltext@MSK | Save
  • Commentary: Sorafenib - The end of a long journey in search of systemic therapy for hepatocellular carcinoma, or the beginning?
    Journal Article

    Abou-Alfa, G. K.
    The Oncologist (2009)

    Fulltext@MSK | Save
  • Managing cirrhosis: New data on liver disease complications - Commentary
    Journal Article

    Abou-Alfa, G. K.
    Gastroenterology & Hepatology (2009)

    Fulltext@MSK | Save
  • Selection of patients with hepatocellular carcinoma for sorafenib
    Journal Article

    Abou-Alfa, G. K.
    Journal of the National Comprehensive Cancer Network (2009)

    Fulltext@MSK | Save
  • A phase II study of docetaxel (D) followed by flavopiridol (F) in advanced, gemcitabine-refractory pancreatic cancer (PC)
    Meeting Abstract

    Carvajal, R. D.; Shah, M. A.; Tse, A.; Lefkowitz, R.; Kelsen, D. P.; Schwartz, G. K.; O'Reilly, E. M.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Docetaxel clearance and cisplatin administration: Implications for toxicity of docetaxel, cisplatin, and fluorouracil (DCF) in gastric cancer
    Meeting Abstract

    Power, D. G.; Wu, N.; Qin, W.; Sully, D.; Cisek, C.; Randazzo, J.; Ritch, P. S.; Jhawer, M. P.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Correlation of history of tobacco consumption and type of k-ras mutation in patients (pts) with pancreatic adenocarcinoma (PC)
    Meeting Abstract

    Kelsen, D. P.; O'Reilly, E. M.; Huitzil Melendez, F. D.; Zheng, J.; Capanu, M.; Duffy, A.; Gansukh, B.; Jacobs, G.; Chapman, P. B.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Pancreatic adenocarcinoma (PAC) in a younger patient population: 10-year experience at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Duffy, A.; Capanu, M.; Allen, P.; Kurtz, R.; Ludwig, E.; Olson, S.; Klimstra, D.; Abou-Alfa, G. K.; Kelsen, D. P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save